Population Screening for Colorectal Cancer Means Getting FIT: The Past, Present, and Future of Colorectal Cancer Screening Using the Fecal Immunochemical Test for Hemoglobin (FIT)

被引：144
作者：
Allison, James E. [1 ,2 ]
Fraser, Callum G. [3 ]
Halloran, Stephen P. [4 ,5 ]
Young, Graeme P. [6 ]
机构：
[1] Univ Calif San Francisco, Sch Med, Div Gastroenterol, San Francisco, CA 94110 USA
[2] Kaiser Permanente No Calif, Div Res, Oakland, CA USA
[3] Univ Dundee, Ctr Res Canc Prevent & Screening, Sch Med, Dundee, Scotland
[4] Royal Surrey Cty Hosp, NHS Bowel Canc Screening Southern Programme Hub, Guildford, Surrey, England
[5] Univ Surrey, Guildford GU2 5XH, Surrey, England
[6] Flinders Univ S Australia, Flinders Ctr Innovat Canc, Bedford Pk, SA 5042, Australia
来源：
GUT AND LIVER | 2014年 / 8卷 / 02期
关键词：
Population screening; Colorectal cancer; Fecal immunochemical test for hemoglobin; Colorectal cancer screening; OCCULT-BLOOD-TESTS; RANDOMIZED CONTROLLED-TRIAL; AMERICAN-COLLEGE; PARTICIPATION; RISK; COLONOSCOPY; PERFORMANCE; SIGMOIDOSCOPY; MORTALITY; IMPROVES;
D O I：
10.5009/gnl.2014.8.2.117
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
Fecal immunochemical tests for hemoglobin (FIT) are changing the manner in which colorectal cancer (CRC) is screened. Although these tests are being performed worldwide, why is this test different from its predecessors? What evidence supports its adoption? How can this evidence best be used? This review addresses these questions and provides an understanding of FIT theory and practices to expedite international efforts to implement the use of FIT in CRC screening.
引用
收藏
页码：117 / 130
页数：14
相关论文
共 86 条
[21]   Quantitation of Hemoglobin Improves Fecal Immunochemical Tests for Noninvasive Screening [J].
Fraser, Callum G. ;
Allison, James E. ;
Young, Graeme P. ;
Halloran, Stephen P. .
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2013, 11 (07) :839-840
[22]   A future for faecal haemoglobin measurements in the medical laboratory [J].
Fraser, Callum G. .
ANNALS OF CLINICAL BIOCHEMISTRY, 2012, 49 :518-526
[23]   A Proposal to Standardize Reporting Units for Fecal Immunochemical Tests for Hemoglobin [J].
Fraser, Callum G. ;
Allison, James E. ;
Halloran, Stephen P. ;
Young, Graeme P. .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2012, 104 (11) :810-814
[24]   Newer Fecal Tests: Opportunities for Professionals in Laboratory Medicine [J].
Fraser, Callum G. ;
Allison, James E. ;
Young, Graeme P. ;
Halloran, Stephen P. .
CLINICAL CHEMISTRY, 2012, 58 (06) :963-965
[25]  
Fraser CG, 2013, CLIN CHEM LAB MED, P1
[26]   Influence of seasonal variations in ambient temperatures on performance of immunochemical faecal occult blood test for colorectal cancer screening: observational study from the Florence district [J].
Grazzini, Grazia ;
Ventura, Leonardo ;
Zappa, Marco ;
Ciatto, Stefano ;
Confortini, Massimo ;
Rapi, Stefano ;
Rubeca, Tiziana ;
Visioli, Carmen Beatriz ;
Halloran, Stephen P. .
GUT, 2010, 59 (11) :1511-1515
[27]   European guidelines for quality assurance in colorectal cancer screening and diagnosis. First Edition Faecal occult blood testing [J].
Halloran, S. P. ;
Launoy, G. ;
Zappa, M. .
ENDOSCOPY, 2012, 44 :SE65-SE87
[28]   Randomised controlled trial of faecal-occult-blood screening for colorectal cancer [J].
Hardcastle, JD ;
Chamberlain, JO ;
Robinson, MHE ;
Moss, SM ;
Amar, SS ;
Balfour, TW ;
James, PD ;
Mangham, CM .
LANCET, 1996, 348 (9040) :1472-1477
[29]   Primary care endorsement letter and a patient leaflet to improve participation in colorectal cancer screening: results of a factorial randomised trial [J].
Hewitson, P. ;
Ward, A. M. ;
Heneghan, C. ;
Halloran, S. P. ;
Mant, D. .
BRITISH JOURNAL OF CANCER, 2011, 105 (04) :475-480
[30]   Risk of colorectal cancer seven years after flexible sigmoidoscopy screening: randomised controlled trial [J].
Hoff, Geir ;
Grotmol, Tom ;
Skovlund, Eva ;
Bretthauer, Michael .
BMJ-BRITISH MEDICAL JOURNAL, 2009, 338 :1363-1365
123456789